Context Therapeutics CNTX
NASDAQ CNTX
$0.17 +0.00 (+0.00%)
At close: Nov 19, 2026 · 4:00 PM EST

Context Therapeutics (CNTX) Depreciation & Amortization (CF) (2022 - 2026)

Updated

Context Therapeutics' Depreciation & Amortization (CF) was $7,469 in Q3 2026, up 83.7% from $4,066 a year earlier and up 12.4% from the prior quarter.

Analysis

Context Therapeutics (CNTX) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends

On a trailing twelve-month basis, Context Therapeutics' Depreciation & Amortization (CF) was $22,868 through Sep 30, 2026, up 51.2% year-over-year; for FY2025, it came in at $16,251, up 49.4% from FY2024.

  • Depreciation & Amortization (CF) shows a three-year compound annual growth rate of 20.6% (FY2022 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $10,881 in FY2024 (-9.7%), $12,044 in FY2023 (+30.0%) and $9,268 in FY2022.
  • The Q3 2026 figure marks the highest quarterly Depreciation & Amortization (CF) in data going back to Q2 2022.
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for eight straight quarters, with growth averaging 47.1% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2026 (growth of 83.7%); the worst was Q4 2023 (a decline of 19.6%).
  • Per Business Quant data, CNTX's Depreciation & Amortization (CF) in the three quarters before Q3 2026 was $6,647 (Q2 2026), $4,687 (Q1 2026) and $4,065 (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 33,835.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 545.00 Mn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 2.12 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn 192.00 Mn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 726.00 Mn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 1.12 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 132.00 Mn
9 Gsk 193.54 Bn 176.38 Bn - -
10 Context Therapeutics 15.24 Mn -182.70 Mn - 7,469.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 7,469.00
Jun 30, 2026 6,647.00
Mar 31, 2026 4,687.00
Dec 31, 2025 4,065.00
Sep 30, 2025 4,066.00
Jun 30, 2025 4,065.00
Mar 31, 2025 4,055.00
Dec 31, 2024 2,934.00
Sep 30, 2024 2,811.00
Jun 30, 2024 2,568.00
Mar 31, 2024 2,568.00
Dec 31, 2023 2,568.00
Sep 30, 2023 3,089.00
Jun 30, 2023 3,194.00
Mar 31, 2023 3,193.00
Dec 31, 2022 3,194.00
Sep 30, 2022 3,193.00
Jun 30, 2022 2,881.00
API Access

Context Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CNTX&period=max&api_key=YOUR_API_KEY